BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

  June 2, 2025

   · 

  2 min read
• Press Releases

  Bitterroot Bio Announces Dosing of First Patient in MATADOR Phase 2a Study of BRB-002, an Immunomodulating Therapy Targeting CD47 in Atherosclerotic Cardiovascular Disease

  June 2, 2025

   · 

  3 min read
• Press Releases

  BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen

  June 2, 2025

   · 

  7 min read
• Press Releases

  Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) for the Treatment of Glioblastoma at the ASCO 2025 Annual Meeting

  June 2, 2025

   · 

  5 min read
• Press Releases

  IQVIA Announces Offering of Senior Notes

  June 2, 2025

   · 

  3 min read
• Press Releases

  National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening

  June 2, 2025

   · 

  4 min read
• Press Releases

  ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP as 1st-line therapy in patients with HER2-positive metastatic breast cancer in DESTINY-Breast09 Phase III trial

  June 2, 2025

   · 

  19 min read
• Press Releases

  Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research

  June 2, 2025

   · 

  4 min read
• Press Releases

  Seismic Therapeutic Appoints Sophie Jones, M.D., as Chief Financial Officer

  June 2, 2025

   · 

  2 min read
• Press Releases

  Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML

  June 2, 2025

   · 

  4 min read